Advanced Wound Dressing Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)
Description
The global advanced wound dressing market was valued at USD 8.66 Billion in 2024, driven by the emphasis on treating chronic wounds occurring due to diabetes, obesity, and age across the globe. The market is expected to grow at a CAGR of 4.30% during the forecast period of 2025-2034, with the values likely to rise from USD 13.19 Billion by 2034.
Global Advanced Wound Dressing Market Overview
Advanced wound dressings are used as an intervention on chronic wounds, diabetic ulcers, and arterial leg ulcers, among others. It includes a range of compositions and combinations, used to treat variety of indications. Collagen products, biological skin equivalents (BSE), biological dressings (BD), silver dressings, are amongst commonly used advanced wound dressings. The market is driven by increased research and development activities in the medical domain intended to develop improved outcomes for patients.
Global Advanced Wound Dressing Market Trends
Growing Investment in the Wound Care Sector
One of the major market trends is the increased funding to accelerate the advancement in wound care management. Innovations in wound care technologies, such as antimicrobial dressings, smart wound care devices, and bioengineered dressing are attracting considerable investor attention. Moreover, this surge in investments in the advanced wound dressing market can be attributed to the increasing demand for effective wound care solutions and the rising cases of chronic and acute wounds, with acute and chronic wounds affecting more than 6 million people in the United States alone . Further, around 100 million patients are affected by chronic wounds including diabetic foot, venous leg, and pressure ulcers. Additionally, the prevalence of these wounds is estimated to increase by 12% annually owing to the increasing burden of underlying diseases like diabetes and obesity, and the growing aging population. Such factors are projected to positively influence the advanced wound care market dynamics in the near future.
In May 2024, the National Institute of Chemical Physics and Biophysics (Estonia) spin-off MedTech company Nanordica Medical raised Euro 1.75 million to introduce its wound care products including its advanced antibacterial dressing into the market. The company’s innovative dressing combines silver and nanoparticles to enhance the antibacterial efficacy of both components and expedite wound healing. Compared to traditional antibacterial solutions, Nanordica Medical’s dressing inactivated bacterial infection 8 times better, showing its efficiency in curing severe wounds. The firm also plans to conduct a multicentered study enrolling 170 patients with diabetic foot ulcers in Q2 2024, with its first human wound care product planned to be launched in 2025. Thus, these investment initiatives are set to drive innovation and expand product offerings in the market._x000D_
Increased Clinical Trial Activity to Meet the Rising Advanced Wound Dressing Market Demand
To accommodate the growing demand for advanced wound dressings, the key market players are heavily investing in conducting clinical trials to assess the efficacy and safety profile of new products and build trust among healthcare providers and patients. For example, in May 2024, pioneering medical products and technologies company, Convatech, announced positive clinical study results of its AQUACEL® Ag+ Extra™dressing that supports its superiority in the management of venous leg ulcers as compared to standard-of-care dressings. The findings were revealed in a recent multinational randomized controlled trial (RCT) conducted across 20 sites in Germany, the United Kingdom, and Colombia, suggesting that Convatech’s dressing can offer an effective means to manage hard-to-heal wounds. Such clinical studies also reflect a substantial growth in advanced wound dressing market technologies.
The study further demonstrated that venous leg ulcers when managed with AQUACEL® Ag+ Extra™ dressing were likely to have a 40% wound area reduction in 4 weeks and 31% more likely to heal completely at 12 weeks. Further, strong evidence of the high healing capacity of the advanced dressing was reported in the data, with 74.8% of venous leg ulcers completely healing using Convatec products in contrast to 55.6% of them healing using standard-of-care dressing. Such results highlight the clinical value of AQUACEL® Ag+ Extra™ which combines Hydrofiber® technology and MORE THAN SILVER™ technology. Thus, the growth in clinical trials to establish evidence-based data on antimicrobial and antibiofilm wound dressings is one of the major wound care market trends that is anticipated to bolster the market growth in the forecast period.
Recent Developments in the Global Advanced Wound Dressing Market
Regulatory Approvals Support the Market Growth
Recent market developments reveal an increase in wound care product approvals from health regulatory bodies such as the United States Food and Drug Administration (FDA). Several advanced wound dressings such as antimicrobial dressings, bioactive dressings, and negative pressure wound therapy devices have received market authorization which directly impacts the advanced wound dressing market growth. Further, faster approval of novel wound care solutions also facilitates the rapid adoption of these advanced wound dressings in healthcare facilities.
In April 2023, the first-ever FDA approval was granted to 3M™ Veraflo™ Therapy (3M™ Veraflo™ Cleanse Choice Complete™ Dressing and 3M™ V.A.C. Veraflo Cleanse Choice™ Dressing) developed by 3M Health Care for hydromechanical removal of infectious materials, non-viable tissue, and wound debris. This negative pressure wound therapy (NPWT) dressings products promotes granulation tissue formation and reduces the number of surgical debridements required while simultaneously creating an environment that promotes wound healing. Thus, by minimizing the need for surgical debridement and stimulating faster healing, these two 3M Veraflo Therapy dressings reduce associated healthcare costs. Thus, the presence of a favorable regulatory framework is essential to ensure rapid adoption and market penetration of advanced wound care products and acts as a significant growth driver for the advanced wound dressing market.
Increasing Strategic Partnerships Elevates the Market Value
Another key development in the market is the rise in strategic partnerships that catalyze growth, innovation, and market expansion. Mergers and acquisition activities are accelerating the market entry of new products, improving the distribution and availability of advanced wound dressings. Additionally, increasing collaborations among companies, research institutions, healthcare providers, and other organizations is one of the significant wound care market trends and is expected to elevate the market value of advanced wound care technologies and solutions.
In March 2022, global medical products and technologies company Convatec Group Plc completed the acquisition of regenerative medicine company Triad Life Sciences Inc to gain market entry to the rapidly growing wound biologics segment. As part of the acquisition, the current portfolio of the Triad team and product pipeline including skin substitutes and active collagen dressings will transition to Convatec’s Advanced Wound Care (AWC) business and be branded as Convatec Advanced Tissue Technologies. Triad’s innovative products such as FDA-cleared InnovaMatrixAC and InnovaMatrixFS are based on porcine placental tissue and are effective in the treatment of hard-to-heal wounds and thus are expected to strengthen Convatec’s presence in advanced wound dressing market.
Overall, strategic partnerships enable companies to expand their offerings and establish a strong presence in a new market segment. Co-development agreements further allow the sharing of research costs and pooling of expertise, ultimately resulting in faster product development cycles.
Launch of Novel Wound Care Products Boosts Market Share
The launch of novel wound care solutions is a significant development that affects the advanced wound care market dynamics. These innovative products are designed to improve clinical outcomes and enhance the patient's quality of life by reducing healing times. Manufacturers are also investing in the development of advanced wound dressings with superior wound-cleansing properties.
For instance, in June 2023, JeNaCell, a part of Evonik, also launched a moist wound dressing called Epicite® balance for chronic wound treatment in the German market. This wound dressing can be used to heal diabetic foot ulcers, venous or arterial leg ulcers, pressure ulcers, and soft tissue lesions. It is designed to treat chronic wounds with low to medium exudates. Epicite Balance, available in three different sizes, will be distributed to hospitals and homecare centers through the firm Coopmed ApS. Thus, with the ongoing developments, the advanced wound dressing market is poised to experience a sustained demand.
Further, a wireless sensor inbuilt smart bandage has also been introduced in the market, focused on treating chronic wounds. It uses electrical stimulation and biosensors to facilitate wound healing and decrease scar formation by increasing blood flow to the injured tissue. Moreover, the market is also witnessing an increased focus on patient comfort and convenience, such as easy-to-apply dressings and products that reduce dressing change pain and frequency.
Global Advanced Wound Dressing Market Segmentation
Advanced Wound Dressing Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Products Foam Dressing
Hydrocolloid dressings
Film Dressing
Alginate Dressing
Hydrogel Dressing
Collagen Dressing
Other Advanced Dressing
Surgical Wound Care Tissue adhesive and Sealants
Anti-infective Dressing Medical Tap
Cotton
Bandages
Gauze
Sponges
Cleansing Agents
Others Negative Pressure Devices
Oxygen and hyperbaric oxygen equipment
Electric stimulation devices
Pressure Relief Devices
Others
Market Segmentation Based on Products Witnessing Significant Market Growth
Based on products, the market is broadly segmented into advanced wound dressings, surgical wound care, traditional wound dressing, and wound dressing devices. Advanced wound dressings include products like collagen dressings, foam dressing, hydrocolloid dressings, film dressing and biological dressings, among others. Each specialized product is designed to cater to distinct wound care needs. For infection management, wound care market trends indicate the preference for antimicrobial dressings containing agents such as silver and iodine for controlling and preventing infections. In exudate management, foam dressings and hydrocolloid dressings are popular in healthcare facilities. Foam dressings cover a major share of the advanced wound dressing market. They maintain a moist wound environment and are known for their high absorption quality. On the other hand, hydrocolloid dressings promote autolytic debridement besides offering a moist environment._x000D__x000D_
Biological dressings are used to enhance the natural healing process of complex wounds by utilizing skin substitutes and growth factors. Therapy devices such as negative pressure wound therapy, hyperbaric oxygen therapy, and electrical stimulation devices offer innovative technological solutions for stimulating wound healing and are poised to fuel advanced wound dressing market growth in the forecast period.
Application Segment is Anticipated to Hold a Substantial Market Value
The market is segmented by applications into chronic wounds and acute wounds. Chronic wounds require long-term management and specialized dressings and include diabetic foot ulcers, venous leg ulcers, and arterial ulcers, among others. In contrast, acute wounds heal at a predictable rate and comprise surgical wounds, traumatic wounds, lacerations, abrasions, and burn injuries. This wounds category benefits from the advanced wound dressings that ensure quick and effective healing.
Global Advanced Wound Dressing Market Regional Analysis
North America is Leading the Market Share in Advanced Wound Care Solutions
Based on the region, the advanced wound dressing market covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. A significant portion of the market share was dominated by North America during the historic period. The presence of key healthcare players is a major factor in its prominent presence in the market. For instance, Convatec Group Plc has acquired a new anti-invective nitric oxide technology from 30 Technology Limited to expand its research and development in advanced wound care. The LifeNet Health acquisition of Bioventus can also bring some major development in the advanced wound care market industry in the coming years.
Europe holds a large market share and is also bringing some innovative developments to the market landscape. Researchers from Sweden have developed nanocellulose-made wound dressing to reveal early detection of infection in the wound without disrupting the wound healing process. Moreover, Coloplast, a Danish company, has also acquired Kerecis, an Iceland-based biologic wound care for USD 1.3 billion. This firm utilizes fish skin to develop tissue-transplant products. Hence, we can assume the European market will grow as well.
Global Advanced Wound Dressing Market: Competitive Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the advanced wound dressing market are as follows:
3M (Acelity Inc.)
3M, an American corporation manufactures a wide range of healthcare products, including advanced wound care products. It is involved in strategic partnerships to expand its offering in advanced and surgical wound care. For instance, it acquired a leading global medical technology company specializing in advanced wound care and specialty surgical applications Acelity Inc ., and its KCI subsidiaries in 2019 in a deal worth USD 6.7 billion.
Adynxx, Inc.
Adynxx, Inc. a United States-based clinical-stage biopharmaceutical company, is leveraging its hydrogel technology platform to develop a broad spectrum of advanced wound care management solutions.
B. Braun Melsungen AG
This German medical and pharmaceutical device company has a robust advanced wound care portfolio and is particularly known for its antimicrobial silver dressings in the advanced wound dressing market. Its Askina® Calgitrol® range is marketed in two different forms: Askina® Calgitrol® Ag+ (an antimicrobial silver dressing with reinforced fiber) and Askina® Calgitrol® Paste (an amorphous silver alginate matrix available in paste form).
ConvaTec Group plc
This MedTech company is a key market player and is committed to catalyzing wound dressing innovations for progressing chronic care. Its AQUACEL Ag dressings, combining the capabilities of ionic silver and Hydrofiber® technology, are widely used anti-microbial dressings in healthcare settings.
Other players in the market include Essity AB (BSN Medical GmbH), Integra Lifesciences (Derma Sciences), Investor AB (Mölnlycke Health Care AB), Johnson & Johnson, Medline Industries, Inc., Medtronic plc, Coliplast A/S, Sanara MedTech Inc., Fibroheal Woundcare Pvt. Ltd.
The competitive landscape of the advanced wound dressing market is characterized by substantial investment in research and development activities to manufacture new and improved wound care products. Key market players are engaging in mergers and acquisition activities to accelerate product development and expand market reach. Leading providers of advanced surgical dressings are also expanding their presence in emerging markets through local partnerships and distribution agreements.
Key companies in the market are increasingly utilizing new materials like fucoidan, sponges, hydrocolloids, hydrofibers, collagen, hydrogels, and films to advance wound care management. Manufacturers are also focusing on antimicrobial wound dressings that release antiseptics to kill the microorganisms and may contain either silver (Aquacel AG), nano-crystalline silver (ACTICOAT), or cadexomer iodine (Iodosorb™).
Key Questions Answered in the Global Advanced Wound Dressing Market Report
Global Advanced Wound Dressing Market Overview
Advanced wound dressings are used as an intervention on chronic wounds, diabetic ulcers, and arterial leg ulcers, among others. It includes a range of compositions and combinations, used to treat variety of indications. Collagen products, biological skin equivalents (BSE), biological dressings (BD), silver dressings, are amongst commonly used advanced wound dressings. The market is driven by increased research and development activities in the medical domain intended to develop improved outcomes for patients.
Global Advanced Wound Dressing Market Trends
Growing Investment in the Wound Care Sector
One of the major market trends is the increased funding to accelerate the advancement in wound care management. Innovations in wound care technologies, such as antimicrobial dressings, smart wound care devices, and bioengineered dressing are attracting considerable investor attention. Moreover, this surge in investments in the advanced wound dressing market can be attributed to the increasing demand for effective wound care solutions and the rising cases of chronic and acute wounds, with acute and chronic wounds affecting more than 6 million people in the United States alone . Further, around 100 million patients are affected by chronic wounds including diabetic foot, venous leg, and pressure ulcers. Additionally, the prevalence of these wounds is estimated to increase by 12% annually owing to the increasing burden of underlying diseases like diabetes and obesity, and the growing aging population. Such factors are projected to positively influence the advanced wound care market dynamics in the near future.
In May 2024, the National Institute of Chemical Physics and Biophysics (Estonia) spin-off MedTech company Nanordica Medical raised Euro 1.75 million to introduce its wound care products including its advanced antibacterial dressing into the market. The company’s innovative dressing combines silver and nanoparticles to enhance the antibacterial efficacy of both components and expedite wound healing. Compared to traditional antibacterial solutions, Nanordica Medical’s dressing inactivated bacterial infection 8 times better, showing its efficiency in curing severe wounds. The firm also plans to conduct a multicentered study enrolling 170 patients with diabetic foot ulcers in Q2 2024, with its first human wound care product planned to be launched in 2025. Thus, these investment initiatives are set to drive innovation and expand product offerings in the market._x000D_
Increased Clinical Trial Activity to Meet the Rising Advanced Wound Dressing Market Demand
To accommodate the growing demand for advanced wound dressings, the key market players are heavily investing in conducting clinical trials to assess the efficacy and safety profile of new products and build trust among healthcare providers and patients. For example, in May 2024, pioneering medical products and technologies company, Convatech, announced positive clinical study results of its AQUACEL® Ag+ Extra™dressing that supports its superiority in the management of venous leg ulcers as compared to standard-of-care dressings. The findings were revealed in a recent multinational randomized controlled trial (RCT) conducted across 20 sites in Germany, the United Kingdom, and Colombia, suggesting that Convatech’s dressing can offer an effective means to manage hard-to-heal wounds. Such clinical studies also reflect a substantial growth in advanced wound dressing market technologies.
The study further demonstrated that venous leg ulcers when managed with AQUACEL® Ag+ Extra™ dressing were likely to have a 40% wound area reduction in 4 weeks and 31% more likely to heal completely at 12 weeks. Further, strong evidence of the high healing capacity of the advanced dressing was reported in the data, with 74.8% of venous leg ulcers completely healing using Convatec products in contrast to 55.6% of them healing using standard-of-care dressing. Such results highlight the clinical value of AQUACEL® Ag+ Extra™ which combines Hydrofiber® technology and MORE THAN SILVER™ technology. Thus, the growth in clinical trials to establish evidence-based data on antimicrobial and antibiofilm wound dressings is one of the major wound care market trends that is anticipated to bolster the market growth in the forecast period.
Recent Developments in the Global Advanced Wound Dressing Market
Regulatory Approvals Support the Market Growth
Recent market developments reveal an increase in wound care product approvals from health regulatory bodies such as the United States Food and Drug Administration (FDA). Several advanced wound dressings such as antimicrobial dressings, bioactive dressings, and negative pressure wound therapy devices have received market authorization which directly impacts the advanced wound dressing market growth. Further, faster approval of novel wound care solutions also facilitates the rapid adoption of these advanced wound dressings in healthcare facilities.
In April 2023, the first-ever FDA approval was granted to 3M™ Veraflo™ Therapy (3M™ Veraflo™ Cleanse Choice Complete™ Dressing and 3M™ V.A.C. Veraflo Cleanse Choice™ Dressing) developed by 3M Health Care for hydromechanical removal of infectious materials, non-viable tissue, and wound debris. This negative pressure wound therapy (NPWT) dressings products promotes granulation tissue formation and reduces the number of surgical debridements required while simultaneously creating an environment that promotes wound healing. Thus, by minimizing the need for surgical debridement and stimulating faster healing, these two 3M Veraflo Therapy dressings reduce associated healthcare costs. Thus, the presence of a favorable regulatory framework is essential to ensure rapid adoption and market penetration of advanced wound care products and acts as a significant growth driver for the advanced wound dressing market.
Increasing Strategic Partnerships Elevates the Market Value
Another key development in the market is the rise in strategic partnerships that catalyze growth, innovation, and market expansion. Mergers and acquisition activities are accelerating the market entry of new products, improving the distribution and availability of advanced wound dressings. Additionally, increasing collaborations among companies, research institutions, healthcare providers, and other organizations is one of the significant wound care market trends and is expected to elevate the market value of advanced wound care technologies and solutions.
In March 2022, global medical products and technologies company Convatec Group Plc completed the acquisition of regenerative medicine company Triad Life Sciences Inc to gain market entry to the rapidly growing wound biologics segment. As part of the acquisition, the current portfolio of the Triad team and product pipeline including skin substitutes and active collagen dressings will transition to Convatec’s Advanced Wound Care (AWC) business and be branded as Convatec Advanced Tissue Technologies. Triad’s innovative products such as FDA-cleared InnovaMatrixAC and InnovaMatrixFS are based on porcine placental tissue and are effective in the treatment of hard-to-heal wounds and thus are expected to strengthen Convatec’s presence in advanced wound dressing market.
Overall, strategic partnerships enable companies to expand their offerings and establish a strong presence in a new market segment. Co-development agreements further allow the sharing of research costs and pooling of expertise, ultimately resulting in faster product development cycles.
Launch of Novel Wound Care Products Boosts Market Share
The launch of novel wound care solutions is a significant development that affects the advanced wound care market dynamics. These innovative products are designed to improve clinical outcomes and enhance the patient's quality of life by reducing healing times. Manufacturers are also investing in the development of advanced wound dressings with superior wound-cleansing properties.
For instance, in June 2023, JeNaCell, a part of Evonik, also launched a moist wound dressing called Epicite® balance for chronic wound treatment in the German market. This wound dressing can be used to heal diabetic foot ulcers, venous or arterial leg ulcers, pressure ulcers, and soft tissue lesions. It is designed to treat chronic wounds with low to medium exudates. Epicite Balance, available in three different sizes, will be distributed to hospitals and homecare centers through the firm Coopmed ApS. Thus, with the ongoing developments, the advanced wound dressing market is poised to experience a sustained demand.
Further, a wireless sensor inbuilt smart bandage has also been introduced in the market, focused on treating chronic wounds. It uses electrical stimulation and biosensors to facilitate wound healing and decrease scar formation by increasing blood flow to the injured tissue. Moreover, the market is also witnessing an increased focus on patient comfort and convenience, such as easy-to-apply dressings and products that reduce dressing change pain and frequency.
Global Advanced Wound Dressing Market Segmentation
Advanced Wound Dressing Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Products
- Advanced Wound Dressing
- Sutures and Staples
- Traditional Wound Dressing
- Wound Dressing/Care Devices
- Others
- Chronic Wound
- Acute Wound
- Hospitals
- Community Health Service Centres
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Segmentation Based on Products Witnessing Significant Market Growth
Based on products, the market is broadly segmented into advanced wound dressings, surgical wound care, traditional wound dressing, and wound dressing devices. Advanced wound dressings include products like collagen dressings, foam dressing, hydrocolloid dressings, film dressing and biological dressings, among others. Each specialized product is designed to cater to distinct wound care needs. For infection management, wound care market trends indicate the preference for antimicrobial dressings containing agents such as silver and iodine for controlling and preventing infections. In exudate management, foam dressings and hydrocolloid dressings are popular in healthcare facilities. Foam dressings cover a major share of the advanced wound dressing market. They maintain a moist wound environment and are known for their high absorption quality. On the other hand, hydrocolloid dressings promote autolytic debridement besides offering a moist environment._x000D__x000D_
Biological dressings are used to enhance the natural healing process of complex wounds by utilizing skin substitutes and growth factors. Therapy devices such as negative pressure wound therapy, hyperbaric oxygen therapy, and electrical stimulation devices offer innovative technological solutions for stimulating wound healing and are poised to fuel advanced wound dressing market growth in the forecast period.
Application Segment is Anticipated to Hold a Substantial Market Value
The market is segmented by applications into chronic wounds and acute wounds. Chronic wounds require long-term management and specialized dressings and include diabetic foot ulcers, venous leg ulcers, and arterial ulcers, among others. In contrast, acute wounds heal at a predictable rate and comprise surgical wounds, traumatic wounds, lacerations, abrasions, and burn injuries. This wounds category benefits from the advanced wound dressings that ensure quick and effective healing.
Global Advanced Wound Dressing Market Regional Analysis
North America is Leading the Market Share in Advanced Wound Care Solutions
Based on the region, the advanced wound dressing market covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. A significant portion of the market share was dominated by North America during the historic period. The presence of key healthcare players is a major factor in its prominent presence in the market. For instance, Convatec Group Plc has acquired a new anti-invective nitric oxide technology from 30 Technology Limited to expand its research and development in advanced wound care. The LifeNet Health acquisition of Bioventus can also bring some major development in the advanced wound care market industry in the coming years.
Europe holds a large market share and is also bringing some innovative developments to the market landscape. Researchers from Sweden have developed nanocellulose-made wound dressing to reveal early detection of infection in the wound without disrupting the wound healing process. Moreover, Coloplast, a Danish company, has also acquired Kerecis, an Iceland-based biologic wound care for USD 1.3 billion. This firm utilizes fish skin to develop tissue-transplant products. Hence, we can assume the European market will grow as well.
Global Advanced Wound Dressing Market: Competitive Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the advanced wound dressing market are as follows:
3M (Acelity Inc.)
3M, an American corporation manufactures a wide range of healthcare products, including advanced wound care products. It is involved in strategic partnerships to expand its offering in advanced and surgical wound care. For instance, it acquired a leading global medical technology company specializing in advanced wound care and specialty surgical applications Acelity Inc ., and its KCI subsidiaries in 2019 in a deal worth USD 6.7 billion.
Adynxx, Inc.
Adynxx, Inc. a United States-based clinical-stage biopharmaceutical company, is leveraging its hydrogel technology platform to develop a broad spectrum of advanced wound care management solutions.
B. Braun Melsungen AG
This German medical and pharmaceutical device company has a robust advanced wound care portfolio and is particularly known for its antimicrobial silver dressings in the advanced wound dressing market. Its Askina® Calgitrol® range is marketed in two different forms: Askina® Calgitrol® Ag+ (an antimicrobial silver dressing with reinforced fiber) and Askina® Calgitrol® Paste (an amorphous silver alginate matrix available in paste form).
ConvaTec Group plc
This MedTech company is a key market player and is committed to catalyzing wound dressing innovations for progressing chronic care. Its AQUACEL Ag dressings, combining the capabilities of ionic silver and Hydrofiber® technology, are widely used anti-microbial dressings in healthcare settings.
Other players in the market include Essity AB (BSN Medical GmbH), Integra Lifesciences (Derma Sciences), Investor AB (Mölnlycke Health Care AB), Johnson & Johnson, Medline Industries, Inc., Medtronic plc, Coliplast A/S, Sanara MedTech Inc., Fibroheal Woundcare Pvt. Ltd.
The competitive landscape of the advanced wound dressing market is characterized by substantial investment in research and development activities to manufacture new and improved wound care products. Key market players are engaging in mergers and acquisition activities to accelerate product development and expand market reach. Leading providers of advanced surgical dressings are also expanding their presence in emerging markets through local partnerships and distribution agreements.
Key companies in the market are increasingly utilizing new materials like fucoidan, sponges, hydrocolloids, hydrofibers, collagen, hydrogels, and films to advance wound care management. Manufacturers are also focusing on antimicrobial wound dressings that release antiseptics to kill the microorganisms and may contain either silver (Aquacel AG), nano-crystalline silver (ACTICOAT), or cadexomer iodine (Iodosorb™).
Key Questions Answered in the Global Advanced Wound Dressing Market Report
- What is the advanced wound care market?
- What are the key segments of the advanced wound care market?
- What factors are driving the growth of the market?
- What challenges does the market face?
- What are the regional markets covered in the EMR report?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the advanced wound care market forecast period?
- What is market segmentation based on products?
- Where does advanced wound dressing find its application?
- Who are the major end users in the market?
- How does the innovations in wound care products affect the advanced wound care market?
- What recent developments are shaping the advanced wound care market?
- How does the rise in the geriatric population impact the market size?
- What products will dominate the market share?
- Which application area is expected to have a high market value in the coming years?
- Which end user will contribute to significant growth in the market segment?
- What is the future advanced wound care market outlook?
- How has the COVID-19 pandemic impacted the advanced wound care market?
- What are the benefits of advanced wound care products?
- How can one stay updated with trends in the advanced wound care market?
- Who are the major players in the advanced wound care market?
- How do the prevalence and incidence of chronic diseases affect the market landscape?
- How are partnerships, collaborations, and mergers & acquisitions among the key market players shaping the market dynamics?
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Advanced Wound Dressing Market Overview
- 3.1 Global Advanced Wound Dressing Market Historical Value (2018-2024)
- 3.2 Global Advanced Wound Dressing Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Advanced Wound Dressing Market Landscape*
- 5.1 Global Advanced Wound Dressing: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Advanced Wound Dressing: Product Landscape
- 5.2.1 Analysis by Type of Product
- 5.2.2 Analysis by Type of Wound
- 6 Global Advanced Wound Dressing Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Advanced Wound Dressing Market Segmentation (218-2034)
- 7.1 Global Advanced Wound Dressing Market (2018-2034) by Products
- 7.1.1 Market Overview
- 7.1.2 Advanced Wound Dressing
- 7.1.2.1 Foam Dressing
- 7.1.2.2 hydrocolloid dressings
- 7.1.2.3 Film Dressing
- 7.1.2.4 Alginate Dressing
- 7.1.2.5 Hydrogel Dressing
- 7.1.2.6 Collagen Dressing
- 7.1.2.7 Other Advanced Dressing
- 7.1.3 Surgical wound care
- 7.1.3.1 Sutures and Staples
- 7.1.3.2 Tissue adhesive and Sealants
- 7.1.3.3 Anti-infective Dressing
- 7.1.4 Traditional Wound Dressing
- 7.1.4.1 Medical Tap
- 7.1.4.2 Cotton
- 7.1.4.3 Bandages
- 7.1.4.4 Gauze
- 7.1.4.5 Sponges
- 7.1.4.6 Cleansing Agents
- 7.1.4.7 Others
- 7.1.5 Wound Dressing/Care Devices
- 7.1.5.1 Negative Pressure Devices
- 7.1.5.2 Oxygen and hyperbaric oxygen equipment
- 7.1.5.3 Electric stimulation devices
- 7.1.5.4 Pressure Relief Devices
- 7.1.5.5 Others
- 7.1.6 Others
- 7.2 Global Advanced Wound Dressing Market (2018-2034) by Wound
- 7.2.1 Market Overview
- 7.2.2 Chronic Wound
- 7.2.3 Acute Wound
- 7.3 Global Advanced Wound Dressing Market (2018-2034) by End User
- 7.3.1 Market Overview
- 7.3.2 Hospitals
- 7.3.3 Community Health Service Centres
- 7.4 Global Advanced Wound Dressing Market (2018-2034) by Region
- 7.4.1 Market Overview
- 7.4.2 North America
- 7.4.3 Europe
- 7.4.4 Asia Pacific
- 7.4.5 Latin America
- 7.4.6 Middle East and Africa
- 8 North America Advanced Wound Dressing Market (218-2034)
- 8.1 North America Advanced Wound Dressing Market (2018-2034) by Product
- 8.1.1 Market Overview
- 8.1.2 Advanced Wound Dressing
- 8.1.2.1 Foam Dressing
- 8.1.2.2 hydrocolloid dressings
- 8.1.2.3 Film Dressing
- 8.1.2.4 Alginate Dressing
- 8.1.2.5 Hydrogel Dressing
- 8.1.2.6 Collagen Dressing
- 8.1.2.7 Other Advanced Dressing
- 8.1.3 Surgical wound care
- 8.1.3.1 Sutures and Staples
- 8.1.3.2 Tissue adhesive and Sealants
- 8.1.3.3 Anti-infective Dressing
- 8.1.4 Traditional Wound Dressing
- 8.1.4.1 Medical Tap
- 8.1.4.2 Cotton
- 8.1.4.3 Bandages
- 8.1.4.4 Gauze
- 8.1.4.5 Sponges
- 8.1.4.6 Cleansing Agents
- 8.1.4.7 Others
- 8.1.5 Wound Dressing/Care Devices
- 8.1.5.1 Negative Pressure Devices
- 8.1.5.2 Oxygen and hyperbaric oxygen equipment
- 8.1.5.3 Electric stimulation devices
- 8.1.5.4 Pressure Relief Devices
- 8.1.5.5 Others
- 8.1.6 Others
- 8.2 North America Advanced Wound Dressing Market (2018-2034) by Wound
- 8.2.1 Market Overview
- 8.2.2 Chronic Wound
- 8.2.3 Acute Wound
- 8.3 North America Advanced Wound Dressing Market (2018-2034) by End User
- 8.3.1 Market Overview
- 8.3.2 Hospitals
- 8.3.3 Community Health Service Centres
- 8.4 North America Advanced Wound Dressing Market (2018-2034) by Country
- 8.4.1 United States of America
- 8.4.2 Canada
- 9 Europe Advanced Wound Dressing Market (218-2034)
- 9.1 Europe Advanced Wound Dressing Market (2018-2034) by Product
- 9.1.1 Market Overview
- 9.1.2 Advanced Wound Dressing
- 9.1.2.1 Foam Dressing
- 9.1.2.2 hydrocolloid dressings
- 9.1.2.3 Film Dressing
- 9.1.2.4 Alginate Dressing
- 9.1.2.5 Hydrogel Dressing
- 9.1.2.6 Collagen Dressing
- 9.1.2.7 Other Advanced Dressing
- 9.1.3 Surgical wound care
- 9.1.3.1 Sutures and Staples
- 9.1.3.2 Tissue adhesive and Sealants
- 9.1.3.3 Anti-infective Dressing
- 9.1.4 Traditional Wound Dressing
- 9.1.4.1 Medical Tap
- 9.1.4.2 Cotton
- 9.1.4.3 Bandages
- 9.1.4.4 Gauze
- 9.1.4.5 Sponges
- 9.1.4.6 Cleansing Agents
- 9.1.4.7 Others
- 9.1.5 Wound Dressing/Care Devices
- 9.1.5.1 Negative Pressure Devices
- 9.1.5.2 Oxygen and hyperbaric oxygen equipment
- 9.1.5.3 Electric stimulation devices
- 9.1.5.4 Pressure Relief Devices
- 9.1.5.5 Others
- 9.1.6 Others
- 9.2 Europe Advanced Wound Dressing Market (2018-2034) by Wound
- 9.2.1 Market Overview
- 9.2.2 Chronic Wound
- 9.2.3 Acute Wound
- 9.3 Europe Advanced Wound Dressing Market (2018-2034) by End User
- 9.3.1 Market Overview
- 9.3.2 Hospitals
- 9.3.3 Community Health Service Centres
- 9.4 Europe Advanced Wound Dressing Market (2018-2034) by Country
- 9.4.1 United Kingdom
- 9.4.2 Germany
- 9.4.3 France
- 9.4.4 Italy
- 9.4.5 Others
- 10 Asia Pacific Advanced Wound Dressing Market (218-2034)
- 10.1 Asia Pacific Advanced Wound Dressing Market (2018-2034) by Product
- 10.1.1 Market Overview
- 10.1.2 Advanced Wound Dressing
- 10.1.2.1 Foam Dressing
- 10.1.2.2 hydrocolloid dressings
- 10.1.2.3 Film Dressing
- 10.1.2.4 Alginate Dressing
- 10.1.2.5 Hydrogel Dressing
- 10.1.2.6 Collagen Dressing
- 10.1.2.7 Other Advanced Dressing
- 10.1.3 Surgical wound care
- 10.1.3.1 Sutures and Staples
- 10.1.3.2 Tissue adhesive and Sealants
- 10.1.3.3 Anti-infective Dressing
- 10.1.4 Traditional Wound Dressing
- 10.1.4.1 Medical Tap
- 10.1.4.2 Cotton
- 10.1.4.3 Bandages
- 10.1.4.4 Gauze
- 10.1.4.5 Sponges
- 10.1.4.6 Cleansing Agents
- 10.1.4.7 Others
- 10.1.5 Wound Dressing/Care Devices
- 10.1.5.1 Negative Pressure Devices
- 10.1.5.2 Oxygen and hyperbaric oxygen equipment
- 10.1.5.3 Electric stimulation devices
- 10.1.5.4 Pressure Relief Devices
- 10.1.5.5 Others
- 10.1.6 Others
- 10.2 Asia Pacific Advanced Wound Dressing Market (2018-2034) by Wound
- 10.2.1 Market Overview
- 10.2.2 Chronic Wound
- 10.2.3 Acute Wound
- 10.3 Asia Pacific Advanced Wound Dressing Market (2018-2034) by End User
- 10.3.1 Market Overview
- 10.3.2 Hospitals
- 10.3.3 Community Health Service Centres
- 10.4 Asia Pacific Advanced Wound Dressing Market (2018-2034) by Country
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 ASEAN
- 10.4.5 Australia
- 10.4.6 Others
- 11 Latin America Advanced Wound Dressing Market (218-2034)
- 11.1 Latin America Advanced Wound Dressing Market (2018-2034) by Product
- 11.1.1 Market Overview
- 11.1.2 Advanced Wound Dressing
- 11.1.2.1 Foam Dressing
- 11.1.2.2 hydrocolloid dressings
- 11.1.2.3 Film Dressing
- 11.1.2.4 Alginate Dressing
- 11.1.2.5 Hydrogel Dressing
- 11.1.2.6 Collagen Dressing
- 11.1.2.7 Other Advanced Dressing
- 11.1.3 Surgical wound care
- 11.1.3.1 Sutures and Staples
- 11.1.3.2 Tissue adhesive and Sealants
- 11.1.3.3 Anti-infective Dressing
- 11.1.4 Traditional Wound Dressing
- 11.1.4.1 Medical Tap
- 11.1.4.2 Cotton
- 11.1.4.3 Bandages
- 11.1.4.4 Gauze
- 11.1.4.5 Sponges
- 11.1.4.6 Cleansing Agents
- 11.1.4.7 Others
- 11.1.5 Wound Dressing/Care Devices
- 11.1.5.1 Negative Pressure Devices
- 11.1.5.2 Oxygen and hyperbaric oxygen equipment
- 11.1.5.3 Electric stimulation devices
- 11.1.5.4 Pressure Relief Devices
- 11.1.5.5 Others
- 11.1.6 Others
- 11.2 Latin America Advanced Wound Dressing Market (2018-2034) by Wound
- 11.2.1 Market Overview
- 11.2.2 Chronic Wound
- 11.2.3 Acute Wound
- 11.3 Latin America Advanced Wound Dressing Market (2018-2034) by End User
- 11.3.1 Market Overview
- 11.3.2 Hospitals
- 11.3.3 Community Health Service Centres
- 11.4 Latin America Advanced Wound Dressing Market (2018-2034) by Country
- 11.4.1 Brazil
- 11.4.2 Argentina
- 11.4.3 Mexico
- 11.4.4 Others
- 12 Middle East and Africa Advanced Wound Dressing Market (218-2034)
- 12.1 Middle East and Africa Advanced Wound Dressing Market (2018-2034) by Product
- 12.1.1 Market Overview
- 12.1.2 Advanced Wound Dressing
- 12.1.2.1 Foam Dressing
- 12.1.2.2 hydrocolloid dressings
- 12.1.2.3 Film Dressing
- 12.1.2.4 Alginate Dressing
- 12.1.2.5 Hydrogel Dressing
- 12.1.2.6 Collagen Dressing
- 12.1.2.7 Other Advanced Dressing
- 12.1.3 Surgical wound care
- 12.1.3.1 Sutures and Staples
- 12.1.3.2 Tissue adhesive and Sealants
- 12.1.3.3 Anti-infective Dressing
- 12.1.4 Traditional Wound Dressing
- 12.1.4.1 Medical Tap
- 12.1.4.2 Cotton
- 12.1.4.3 Bandages
- 12.1.4.4 Gauze
- 12.1.4.5 Sponges
- 12.1.4.6 Cleansing Agents
- 12.1.4.7 Others
- 12.1.5 Wound Dressing/Care Devices
- 12.1.5.1 Negative Pressure Devices
- 12.1.5.2 Oxygen and hyperbaric oxygen equipment
- 12.1.5.3 Electric stimulation devices
- 12.1.5.4 Pressure Relief Devices
- 12.1.5.5 Others
- 12.1.6 Others
- 12.2 Middle East and Africa Advanced Wound Dressing Market (2018-2034) by Wound
- 12.2.1 Market Overview
- 12.2.2 Chronic Wound
- 12.2.3 Acute Wound
- 12.3 Middle East and Africa Advanced Wound Dressing Market (2018-2034) by End User
- 12.3.1 Market Overview
- 12.3.2 Hospitals
- 12.3.3 Community Health Service Centres
- 12.4 Middle East and Africa Advanced Wound Dressing Market (2018-2034) by Country
- 12.4.1 Saudi Arabia
- 12.4.2 United Arab Emirates
- 12.4.3 Nigeria
- 12.4.4 South Africa
- 12.4.5 Others
- 13 Regulatory Framework
- 13.1 Regulatory Overview
- 13.2 US FDA
- 13.3 EU EMA
- 13.4 INDIA CDSCO
- 13.5 JAPAN PMDA
- 13.6 Others
- 14 Funding and Investment Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Patent Analysis
- 15.1 Analysis by Type of Patent
- 15.2 Analysis by Publication Year
- 15.3 Analysis by Issuing Authority
- 15.4 Analysis by Patent Age
- 15.5 Analysis by CPC Analysis
- 15.6 Analysis by Patent Valuation
- 15.7 Analysis by Key Players
- 16 Strategic Initiatives
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Market Share Analysis, By Region (Top 5 Companies)
- 17.1.1 Market Share Analysis: Global
- 17.1.2 Market Share Analysis: North America
- 17.1.3 Market Share Analysis: Europe
- 17.1.4 Market Share Analysis: Asia-Pacific
- 17.1.5 Market Share Analysis: Others
- 17.2 3M (Acelity Inc.)
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Adynxx, Inc.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 B Braun Melsungen AG
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 ConvaTec Group plc
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Essity AB (BSN Medical GmbH)
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Integra Lifesciences (Derma sciences)
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Investor AB (Mölnlycke Health Care AB )
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Johnson & Johnson
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Medline Industries, Inc .
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Medtronic plc
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Coloplast A/S
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Sanara MedTech Inc .
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Fibroheal woundcare pvt. ltd
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
